Clinical Trial Update: Personalized Atrial Fibrillation Ablation With QDOT [Phase 4]

View source ↗

Summary

A Phase 4 trial update on personalized atrial fibrillation ablation using QDOT technology; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• QDOT

Snippet

Sponsor: Antonio Berruezo, MD, PhD | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN